Receptor最新文献

Antibodies can mimic the biological function of physiological ligands, yet few examples indicate the structural similarity between antibodies and the ligands that they mimic. Originally, the competition of antibodies for ligand binding sites was conjectured to be through similar three-dimensional conformations, which represent the "internal image" of the given ligand. Here we show that residues in a complementary determining region (CDR) can adopt the same bioactive structures observed in ligands. Structure-function studies of three anti-GPIIb-IIIa murine monoclonal antibodies, PAC-1, LJ-CP3, and OP-G2, indicate that the RYD sequence in their H-CDR3 domain occupies the same conformational space as RGD in conformationally constrained, bioactive, GPIIb-IIIa cell-surface adhesion ligands. The relative location of the guanidinium and carboxylate groups in the RXD regions is identified as an important recognition feature, and the conformational space occupied by this region in the antibodies is only slightly larger than that in the most bioactive peptides. Additionally, we show that antibodies can unveil other potential bioactive sequences, which may impart specificity. Thus antibodies are an exquisite probe for identifying motifs of short adhesion stretches, thereby revealing amino acid sequences and restricted geometries that might be used as lead compounds in drug design.

A single prostaglandin may have multiple effects on the same cell type with each effect showing a different prostaglandin concentration dependence, indicating the presence of separate receptors coupled to different second-messenger systems. The effects may be antagonistic toward each other, suggesting homeostatic control of prostaglandin effects, which may be important in buffering cellular response to elevated prostaglandin levels in inflammation. We have used prostaglandin regulation of cyclic AMP metabolism in platelets and human erythroleukemia (HEL) cells as a model to analyze interactions between stimulatory and inhibitory prostaglandin receptors coupled to adenylate cyclase. Cloning of an EP3 prostaglandin receptor subtype from HEL cells confirmed the presence of an inhibitory receptor distinct from that involved in prostaglandin stimulation of adenylate cyclase.

Glucocorticoids are very effective anti-inflammatory agents since they affect several of the key mediators responsible for the inflammatory response, including prostaglandins. In particular, under normal physiological conditions, prostaglandin synthesis mediated via the constitutively expressed cyclooxygenase-1 (COX-1) is not affected by endogenously or exogenously administered glucocorticoids. However, within the context of the inflammatory response, phospholipase A2 as well as cyclooxygenase-2 (COX-2) are induced, resulting in an exacerbated production of prostaglandins. The antiinflammatory steroids will reduce inflammation-induced prostaglandin synthesis by inhibiting the expression of these two key enzymes, PLA2 and COX-2.

Cardiac sarcolemmal (SL) phospholipase C (PLC) is a key enzyme in the signal transduction of several cardiac receptors. Thus, the earlier described Ca(2+)-stimulated SL PLC activity may represent variously coupled enzymes. The present study was undertaken to delineate the alpha 1-adrenoceptor/G protein-stimulated PLC activity in purified cardiac SL vesicles. Although certain detergents and membrane pore formers enhanced SL PLC activity, measured as formation of 3H-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] from 3H-phosphatidylinositol 4,5-bisphosphate, alpha 1-adrenoceptor stimulated activity was not observed. When SL vesicles were preincubated (0-4 degrees C) with substrate in detergent-free buffer, subsequent incubation (37 degrees C; in mM: 100 NaCl, 2 EGTA, 1.8 CaCl2, 10 LiCl) resulted in a time-dependent production of 3H-Ins(1,4,5)P3, that was increased in the presence of 100 microM GTP gamma S. GTP gamma S stimulation of SL PLC activity required the presence of Mg2+ and Ca2+, but was lost at (sub)millimolar concentrations of these bivalent cations. Mg2+ (0.01-10 mM) promoted a 2,3-diphosphoglycerate-insensitive phosphatase activity. GTP gamma S enhanced the sensitivity of SL PLC to Ca2+, but did not increase the maximum Ca2+ (0.1-1 mM) stimulated SL PLC activity. At 5 microM Ca2+, GTP gamma S induced a concentration-dependent rise in inositol phosphates production, which was further elevated by the alpha 1-agonist, phenylephrine (PhE). The PhE-effect was inhibited by the alpha 1-antagonist prazosin, but not by the beta-antagonist atenolol. These results show that the components necessary for the alpha 1-adrenoceptor transmembrane signal are associated with the SL membrane and can be functionally coupled.

In this study, the delta receptor-selective nonequilibrium affinity ligands, 5'-NTII and DALCE, and the nonspecific sulfhydryl reagent NEM were evaluated over a range of concentrations and treatment conditions for their ability to selectively alter the binding properties of delta 1- or delta 2-preferring opioid radioligands in brain homogenate. Treatment of tissue preparations with DALCE (0-10,000 nM) or NTII (0-10,000 nM) resulted in an equivalent concentration-dependent loss of binding capacity for the delta 1 agonist 3H-DPDPE and the mu/delta 2 agonist 3H-DSLET. In contrast, treatment of tissue with NEM (0-8000 microM) resulted in greater loss of 3H-DPDPE binding. Scatchard analysis of the binding of 3H-DPDPE, 3H-DSLET, and 3H-NTI in 3 mM NEM-treated rat brain P2 preparation revealed an equivalent decrease in affinity for the agonist ligands, but a significantly greater decrease in Bmax for 3H-DPDPE compared with control tissue values. Comparison of the K(i) values for a series of delta-selective compounds against 3H-DSLET binding in control vs 3 mM NEM treated P2 fraction showed differential effects of NEM on affinity within the series that were consistent with a selective depletion of delta 1 sites. Overall, these results indicate that NEM treatment selectively reduced delta 1 receptor binding, resulting in a preparation that is enriched in delta 2 sites.

The enhancer of the mouse cytochrome P450 cyp1a1 gene, which contains six binding sites (A-F) for the Ah receptor (AhR), has been a useful model system for studying the mechanism of AhR-mediated activation of transcription. In the presence of ligand, AhR interacts with its dimerization partner, Arnt, and the heteromeric complex is able to bind DNA. In the present study, we test the effects of single base pair substitutions of site D on the ability of the AhR/Arnt heteromer to recognize this response element using an in vitro transcription system. Synthetic oligodeoxyribonucleotides corresponding to the wild-type sequence of site D, or single base pair mutations of that sequence, were used to compete for AhR/Arnt binding with the transcription template. Using this competition assay, the sequence of the core recognition motif 5'-GCGTG-3' was shown to be critical for AhR/Arnt binding, and the importance of the position and orientation of the G:C and A:T base pairs of this sequence was determined.

A cDNA encoding a full-length mouse (m) growth hormone receptor (GHR) derived from 3T3 F442A cells was amplified by RT-PCR and cloned into a mammalian expression vector. A mouse L cell line (mGHR1.6), which expresses high levels of full-length mGHR, was established. A mGHR-specific mRNA of approx 2.8 kb was found in these cells. Ligand binding studies showed that mGHR 1.6 cells were capable of binding 125I-hGH with a dissociation constant (Kd) of 2.9 +/- 0.13 nM. Scatchard analysis indicated that mGHR1.6 cells had only a single class of mGHR and possessed approx 128,000 GH specific binding sites per cell. Affinity crosslinking studies showed that the recombinant mGHR possessed an apparent molecular mass of 105 kDa. In addition, mGHR1.6 cells responded to growth hormones (GHs) from several species. Two proteins, pp92 and pp95, were found to be tyrosyl phosphorylated following GH treatment. An hGH antagonist, hGH-G120R, inhibited GH-induced phosphorylation of both pp92 and pp95 in a dose-dependent manner. This cell line may be used as an in vitro model in the studies of GH signal transduction and in the screening of GH analogs for biological activity.

The lateral diffusion rate of glucagon receptor in rat hepatocyte plasma membrane in the absence and presence of glucagon was measured to be approximately 7.0 x 10(-10) cm2/s. The percentage of glucagon receptor molecules remaining on the cell surface after the activation of signal transduction process by 100 nM glucagon was approximately 74% of its original number. Although the number of glucagon receptors on the plasma membrane capable of interacting with its signal transduction partners decreases on addition of glucagon, the lateral diffusion rate and the percentage of mobile receptors remain essentially unchanged. A hypothesis has been developed that for signal transduction to occur, the random diffusion-dependent collision of one, two, or all three components is an essential part, and it may be the rate-limiting step. An approximate calculation has been made of random diffusion-dependent theoretical and experimental collision frequencies using experimentally measured concentrations and reasonable value for diffusion rate of G protein to investigate the role of diffusion in signal transduction. These calculations indicate that the diffusion of individual components is important and may be the rate-limiting step in the signal transduction process. The diffusion rate and percent mobile fraction of glucagon receptor data presented in this article are the first step toward elucidating the validity of the diffusion-dependent signal transduction hypothesis.

LH-RH analogs cause some inhibition of growth of pancreatic cancers. Syrian golden hamsters bearing chemically induced pancreatic cancers were treated with [D-Trp6]LH-RH for 3 d before sacrifice. LH-RH receptors were localized by electron-microscopic immunohistochemistry in the tumor cells of both treated and untreated hamsters. [D-Trp6]LH-RH treatment resulted in a marked increase in the concentration of LH-RH receptors in the nuclei. The dissociation constants (Kd) and the maximal binding capacity of the LH-RH receptors (Bmax), measured by radioreceptor assay, were higher in the nuclei of the pancreatic tumor cells of hamsters treated with [D-Trp6]LH-RH than in the untreated controls. Pancreatic cells of tumor-free hamsters did not show immunostaining for LH-RH receptors. A possible correlation between the increase in the concentration of the LH-RH receptors in the nuclei and the tumor growth-inhibiting activity of [D-Trp6]LH-RH is suggested.

Inflammation is a multicomponent system that involves a network of cellular crosstalk and control. Many different cell types, including neutrophils and platelets, participate as both sources and targets of biological mediators that are generated or released in acute and chronic inflammatory states. Owing to the complex nature of inflammation, the magnitude as well as the spatial and temporal characteristics of the responses are likely to vary with the type, concentration, and duration of the inflammatory stimulus. Despite the potential variations in responses to diverse stimuli, a feature common to and responsible for the major characteristics of inflammation (heat, pain, redness, swelling) is proteases. In the early stages of inflammation, the neutrophil is the predominant cell to infiltrate the tissue, and the extent of inflammatory injury has been shown to be directly dependent on the extent of neutrophil infiltration. Since both cathepsin G and elastase are neutral serine proteases present in large amounts in azurophilic granules and are known to affect platelet function, it is thus likely that these neutrophil enzymes are important contributing factors to inflammatory reactions in general and to neutrophil-platelet interactions specifically.